ALLE vs XYL Stock Comparison
Compare ALLE and XYL across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between ALLE and XYL?
ALLE leads the current stock comparison as Allegion plc, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Allegion plc vs Xylem Inc.
ALLE leads
ALLE leads by 5 AIQ points, primarily on Quality, but the lead has narrowed from 10 points over 30 sessions. Wall Street currently favors XYL on target upside.
Fragile: 3 of 6 evidence groups support ALLE, its lead is narrowing, and its current signal state is conflicted.
Allegion plc
Xylem Inc.
The Algovestiq AIQ Score currently favors ALLE over XYL, 55 versus 50 as of Sep 11, 2026. ALLE's advantage is driven primarily by stronger quality. ALLE also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors XYL. 3 of 6 covered evidence groups favor ALLE today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. ALLE lead: Weakening — the AIQ differential moved from 10 to 5 points over 30 sessions.
Compare Allegion plc and Xylem Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare ALLE and XYL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality68 vs 52ALLE +16
- Momentum27 vs 24Even
- Risk Resilience67 vs 69Even
- Value60 vs 59Even
3 of 6 evidence groups favor ALLE. ALLE’s edge is concentrated in quality.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Risk Resilience +1
No new signals fired.
Largest factor move: Momentum +1
No new signals fired.
ALLE's lead narrowed by 1 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — ALLE and XYL both carry a full feed there.
The central trade-off
ALLE (Allegion plc): the stronger current systematic profile, led by quality.
XYL (Xylem Inc.): the counter-case, on analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
ALLEALLE on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
XYLXYL on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EvenThe two are level on Momentum.
Lower downside
ALLEALLE carries the lower 1-month annualized volatility.
Analyst upside
XYLXYL on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors ALLE, analyst targets favor XYL. That disagreement is the most useful thing on this page.
| Measure | ALLE | XYL | Note |
|---|---|---|---|
| Implied upside to target | +3.7% | +39.9% | XYL has more room |
| Target dispersion | +17.6% | +23.4% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 2 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor ALLE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | ALLE | 55 vs 50 |
| Fundamentals | ALLEon balance | revenue growth 11.4% vs 9.9%; EPS growth 34.4% vs 40.5%; TTM ROE 32% vs 9.2%; gross margin 44.8% vs 39.2%; operating margin 20.8% vs 14.5% — ALLE takes 4 of 5 decided legs, not all of them |
| Valuation | Even | Value 60 vs 59 |
| Technicals | ALLE | Price vs 50-day -0.1% vs -8.5%; vs 200-day 0.2% vs -13.9% |
| Risk Resilience | Even | Risk Resilience 67 vs 69 |
| Analyst expectations | XYL | Target upside 3.7% vs 39.9% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ALLE and XYL and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ALLE.
How the comparison changed
119 daily snapshots · May 4 – Sep 10ALLE lead: Weakening — the AIQ differential moved from 10 to 5 points over 30 sessions.
- Today
- ALLE +5
- 55 vs 50
- 7 sessions ago
- ALLE +11
- 60 vs 49
- 30 sessions ago
- ALLE +10
- 62 vs 52
- 90 sessions ago
- ALLE +2
- 64 vs 62
The lead changed hands once in this window, most recently on Jul 20 when ALLE moved ahead of XYL.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 1 bearish, conflicted
- Golden Cross Active — bullish, trend, long horizon (1.67%)
- RSI Oversold - Potential Bounce — bullish, momentum, short horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
0 bullish / 4 bearish
- Death Cross Active — bearish, trend, long horizon (5.83%)
- 52-Week Low Proximity — bearish, risk, long horizon (0.4%)
- Downtrend Structure Active — bearish, trend, long horizon
ALLE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.38%, AIQ 0 points).
Price and the AIQ Score both moved up over the latest session (price +0.38%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1XYL closes the Quality gap — currently 16 points behind, the largest single contributor to ALLE's edge.
- 2XYL's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3ALLE's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 5-point move would eliminate ALLE's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
ALLE leads on balance| Metric | ALLE | XYL |
|---|---|---|
| Revenue growth (YoY) | 11.4% | 9.9% |
| EPS growth (YoY) | 34.4% | 40.5% |
| Gross margin | 44.8% | 39.2% |
| Operating margin | 20.8% | 14.5% |
| Return on equity (TTM) | 32% | 9.2% |
| Debt to equity | 0.96 | 0.29 |
Performance
ALLE leads 5 of 6 windows| Metric | ALLE | XYL |
|---|---|---|
| 1 week (5 sessions) | -2.5% | -0.2% |
| 1 month (20 sessions) | -8.9% | -12.6% |
| 3 months (63 sessions) | 16.9% | -0.5% |
| 6 months (126 sessions) | 3.2% | -12.9% |
| Year to date | -5% | -21.6% |
| 1 year (252 sessions) | -12.1% | -23.9% |
Technicals
ALLE has the stronger structure| Metric | ALLE | XYL |
|---|---|---|
| RSI (14) | 27.2 | 31 |
| ADX (14) | 22.5 | 29.3 |
| Price vs 50-day | -0.1% | -8.5% |
| Price vs 200-day | 0.2% | -13.9% |
| Volatility (1M, annualized) | 20% | 24.5% |
Risk
Split| Metric | ALLE | XYL |
|---|---|---|
| Beta | 0.55 | 0.81 |
| Sharpe ratio | -0.43 | -1.06 |
| Sortino ratio | -0.6 | -1.42 |
| Max drawdown | -30.1% | -30.9% |
| Current drawdown | -15.8% | -30.3% |
| Annualized volatility | 27.4% | 24.9% |
| Value at risk (95%) | -2.3% | -2.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, ALLE or XYL?
On the Algovestiq AIQ Score, ALLE is the stronger of the two as of Sep 11, 2026, scoring 55 against XYL's 50. The edge comes from quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is ALLE or XYL the better buy right now?
ALLE carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.
Why does the AIQ Score favor ALLE over XYL?
The composite weights Quality, Value, Momentum and Risk Resilience. ALLE leads Quality by 16 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, ALLE or XYL?
Analyst price targets imply +3.7% upside for ALLE and +39.9% for XYL, so the Street currently favors XYL. That points the opposite way to the AIQ Score, which favors ALLE. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, ALLE or XYL?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, ALLE or XYL?
XYL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, ALLE or XYL?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, ALLE or XYL?
ALLE is the more resilient of the two, so the other name carries the higher downside risk. ALLE carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is ALLE more profitable than XYL?
ALLE leads on the comparable margin measures — gross margin 44.8% vs 39.2%; operating margin 20.8% vs 14.5%; ttm roe 32% vs 9.2%.
Is ALLE's lead over XYL getting stronger or weaker?
ALLE lead: Weakening — the AIQ differential moved from 10 to 5 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands once in that window, most recently on 2026-07-20, when ALLE moved ahead of XYL.
What would change the ALLE vs XYL verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: XYL closes the Quality gap — currently 16 points behind, the largest single contributor to ALLE's edge; XYL's Death Cross Active resolves — a bearish trend rule currently active against it; ALLE's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 5 points over 30 sessions, and a further 5-point move would eliminate ALLE's advantage entirely.
What do the current signals say about ALLE and XYL?
ALLE: 2 bullish / 1 bearish, conflicted. XYL: 0 bullish / 4 bearish. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ALLE is Golden Cross Active (bullish, long horizon). On XYL it is Death Cross Active (bearish, long horizon).
Compare ALLE and XYL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.